GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Inventories, Finished Goods

Zelira Therapeutics (ASX:ZLD) Inventories, Finished Goods : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Inventories, Finished Goods?

Zelira Therapeutics's quarterly finished goods increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.38 Mil) but then declined from Jun. 2023 (A$0.38 Mil) to Dec. 2023 (A$0.00 Mil).

Zelira Therapeutics's annual finished goods increased from Jun. 2021 (A$0.60 Mil) to Jun. 2022 (A$0.76 Mil) but then declined from Jun. 2022 (A$0.76 Mil) to Jun. 2023 (A$0.38 Mil).


Zelira Therapeutics Inventories, Finished Goods Historical Data

The historical data trend for Zelira Therapeutics's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Inventories, Finished Goods Chart

Zelira Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.60 0.76 0.38

Zelira Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.76 - 0.38 -

Zelira Therapeutics Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Zelira Therapeutics (ASX:ZLD) Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics (ASX:ZLD) Headlines

No Headlines